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Abstract
Purpose Anxiety disorders are common. Prevalence is likely to be raised in people with hearing impairment, who experi-
ence higher rates of associated risk factors. We conducted, to our knowledge, the first systematic review of the prevalence 
and correlates of anxiety in people with hearing impairment.
Methods We searched electronic databases and references of included studies, using predetermined criteria to retrieve 
original research reporting prevalence of anxiety disorders or symptoms in adult, hearing impaired populations. We assessed 
risk of bias using the adapted Newcastle Ottawa Scale.
Results We included 25 studies evaluating 17,135 people with hearing impairment. Community studies of higher quality 
reported a lifetime prevalence of anxiety disorder of 11.1% (one study) and point prevalences of 15.4–31.3% for clini-
cally significant anxiety symptoms (five studies) in people who predominantly had acquired hearing impairment. Anxiety 
prevalence was higher in hearing impaired people in 8/10 studies with a comparator non-hearing impaired group. Anxiety 
symptoms decreased after surgical intervention for hearing in all studies investigating this. Correlates consistently associated 
with anxiety were tinnitus and hearing impairment severity.
Conclusions Prevalence of anxiety is higher among people with hearing impairment than the general population; our findings 
indicate that this excess morbidity may be related to the hearing impairment itself, as it was associated with the severity of 
impairment, and reduced after surgical treatment. Clinicians should be aware of the potential impact of hearing on mental 
health, and that where hearing ability can be improved, this may reduce anxiety.
Prospero registration number CRD42018088463.
Keywords Hearing · Anxiety · Prevalence · Tinnitus
Introduction
An estimated 11 million people in the UK live with sig-
nificant hearing impairment [1]. The majority experience 
‘acquired’ hearing impairment, with onset typically in older 
age. Around 7 per 10,000 have pre-lingual deafness, with 
onset before speech development. They often use sign lan-
guage to communicate and some view deafness as a culture 
rather than as a disability [2, 3].
Anxiety disorders are very common. A 2004 survey 
of over 21,000 adults in Europe estimated the lifetime 
prevalence of any anxiety disorder at 13.6% and the 1-year 
prevalence at 6.4% [4]. According to ICD-10 criteria, anxi-
ety symptoms include persistent nervousness and physical 
symptoms such as muscular tension, palpitations, dizziness, 
and epigastric discomfort [5]. Among proposed risk factors 
for anxiety are cognitive and functional impairments, poorer 
social support networks, loneliness, and traumatic events [6]. 
All of these risk factors are associated with hearing impair-
ment [2, 7, 8]. Hearing impairment can impair verbal com-
munication, increasing social exclusion and loneliness and 
exacerbating existing cognitive and functional impairments. 
It can also lead to greater dependence on others, increasing 
vulnerability to neglect, discrimination or abuse. It is pos-
sible that hearing impaired people may feel a greater sense 
of threat in challenging situations, if they are less able to 
understand what is happening or communicate their needs. 
Although risk factors for anxiety between people with 
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acquired and pre-lingual hearing impairment might dif-
fer, both groups are likely to be at increased risk. Previous 
research has reported that rates of overall mental illness in 
people with hearing impairment are elevated compared with 
hearing populations [2, 3]. To our knowledge, although a 
systematic review of depression and hearing impairment is 
at the time of writing in progress [10], there is no systematic 
review investigating the prevalence and correlates of anxiety 
in hearing impaired people.
We aimed to assimilate evidence regarding the preva-
lence of anxiety disorders and clinically significant anxiety 
symptoms and their correlates among adults with hearing 
impairment.
Methods
We registered our protocol on PROSPERO on the 6th March 
2018 (registration number CRD42018088463). We followed 
PRISMA guidelines when reporting the review.
We searched Medline, Embase, PsycINFO, and AMED 
databases up to 21/2/18 via Ovid interface, and CINAHL 
and LILACS up to 9/4/18 for additional studies. Non-Eng-
lish language studies were excluded as interpreters were 
not available. We used the search terms: hearing or deaf* 
or presbycusis AND anxiety or anxious or OCD or obses-
sive–compulsive disorder or PTSD or post-traumatic stress 
disorder or agoraphobia or panic or phobia or obsess* or 
compuls* or phobic or agoraphobic AND rate or prevalence 
or risk or association or epidemiol* or incidence.
We included original research studies that reported the 
prevalence of anxiety symptoms or disorders, or sufficient 
data to calculate this, in an adult (18+) population with hear-
ing impairment, however defined. Point, period and lifetime 
prevalence were accepted. We excluded studies that reported 
on anxiety symptoms but did not report on the number of 
people reaching pre-specified criteria for significant anxiety. 
We excluded studies that included people aged under 18 or 
people without sustained hearing impairment (unless there 
was a separate hearing impaired sample). We also excluded 
conference and dissertation abstracts, and studies includ-
ing fewer than 30 hearing impaired people, due to the low 
precision of estimates based on small samples. Studies with 
populations with specific genetic syndromes that cause deaf-
ness were excluded due to the high risk of confounding by 
other syndromal symptoms or characteristics.
Where the decision to include or exclude a text was not 
clear, we resolved this by discussion. One-tenth of the study 
abstracts identified by NS from the original search were 
cross-checked by a co-author (CC), who did not identify any 
additional eligible papers. Reference lists of eligible studies 
were then hand-searched for additional studies.
PRISMA flowchart: see Fig. 1
Data were extracted by NS. Where sample size or anxi-
ety prevalence as a percentage was not given, we calcu-
lated this from the available data. Where hearing impair-
ment was divided into subgroups with differing levels of 
impairment, results from these groups were pooled. Some 
hearing impaired groups within studies were not pooled 
however; for example, where it was felt useful to retain a 
subgroup because it reported on patients with a comorbid 
condition. We synthesised findings and presented these 
as a narrative account. We decided a priori that we would 
meta-analyse where outcomes and populations from three 
or more studies were considered to be sufficiently homo-
geneous, by using the metan command in STATA to obtain 
a pooled prevalence [11]. Confidence intervals were gen-
erated using an online calculator [12]. We also identified 
correlates of anxiety in the studies, which we defined as 
measured variables which were associated with anxiety in 
hearing impaired populations.
Study quality
The quality of studies was assessed independently by 
CC and NS using the Newcastle–Ottawa Quality Rating 
Scale (NOS) adapted for cross-sectional studies [13]. We 
discussed any discrepancies in ratings to reach a consen-
sus. This was a deviation from protocol as the NOS was 
found to be more suited to the purpose than the STROBE 
guidelines, which are intended to critically appraise 
studies and does not give a quality score [14]. The NOS 
assesses quality based on sample selection, comparability 
between groups, and outcome assessment. Up to five stars 
are awarded for selection, based on how representative 
the sample is of the target population, whether justifica-
tion is given for the sample size, whether comparability 
between respondents and non-respondents is established, 
and whether the exposure was measured using a validated 
tool. Comparability concerns whether confounders have 
been controlled for between exposure groups and is worth 
two stars. Up to three stars are awarded for outcome being 
measured by independent blind assessment or record link-
age or self-report, and an appropriate statistical test being 
used. As there is no agreed scoring method for the NOS as 
applied to prevalence studies, we judged studies to be of 
higher quality if the following criteria were met: sample 
selection was either (a) truly representative of the aver-
age in the target population (all subjects or random sam-
pling) or (b) somewhat representative of the average in the 
target population (non-random sampling); and measure-
ment of the outcome was clearly described (ideally using 
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independent blind assessment or record linkage). We pri-
oritised studies that were rated as higher quality in our 
narrative synthesis.
Results
Figure 1 illustrates our search strategy results. We included 
25 studies. Most (n = 20) took place in Europe or the USA, 
and most (n = 21) were published in the last 20 years. 19 of 
the studies were of higher quality according to our crite-
ria. 17,135 people with hearing impairment were included, 
with a reported age range from 18 to 101 years. Presence of 
hearing impairment was variably determined by self-report, 
ENT assessment, inclusion on deaf registers and inclusion in 
specialist services for the deaf. 15 studies included a sepa-
rate comparator group.
We did not meta-analyse data, as the broad range of out-
come measures used precluded this. We illustrated results 
with a forest plot, created using STATA version 15.1 [11] 
(see Fig. 2). Results are narratively synthesised below. We 
made a post hoc decision to group studies according to the 
setting, as populations within in ear nose and throat (ENT) 
and within mental health settings appeared to be broadly 
similar.
Anxiety measures
In six studies, anxiety disorder presence was evaluated 
using diagnostic interviews. These were the Composite 
1.3.18: Search of AMED, EMBASE, 
PsychINFO and Medline 
1497 results, 1133 aer de-
duplicaon  
1161 tles and abstracts screenedExcluded aer screening tles and 
abstracts: 
1069 results of which: 
427 not original research 
494 wrong populaon 
128 included children 
17 did not use prevalence of 
anxiety as an outcome 
2 had n < 30 
1 congress abstract 
Full text reviewed
92 
Excluded aer 
screening full text 
74 
Eligible 
18 
Idenfied from 
reference lists 
of eligible 
studies: 7 
Included in 
review 
25 
9/4/18: Search of LILACS and CINAHL Plus 
(De-duplicaon in EndNote) 
28 addional results in English 
Fig. 1  Prisma flowchart
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International Diagnostic Interview (CIDI) [15], the Clini-
cian Administered Post-Traumatic Stress Disorder Scale 
(CAPS) [8], the Stanford Panic Inventory [16], and unspeci-
fied standardised interviews based on the Diagnostic and 
Statistical Manual (DSM) or International Classification 
of Diseases (ICD) [17–19]. Six studies reported on clinical 
diagnoses of anxiety disorder, using accepted diagnostic cri-
teria (ICD or DSM) from medical notes [9, 20–24].
Thirteen studies used measures of anxiety symptoms, two 
of which overlapped with the studies reporting diagnoses 
[16, 18]. Four of the studies reporting symptoms used the 
Hospital Anxiety and Depression Scale-Anxiety (HADS-
A); two with a cut-point for clinical significance of 8 or 
greater [25, 26] and two with a cut-point of 10 or greater 
[27, 28]. These cut-points are validated as indicative of mild 
and severe anxiety, respectively [29]. Three studies used the 
Depression, Anxiety and Stress Scale (DASS), with a cut-
point of 8 or greater in line with the scoring guidance [30, 
31], or not stated [32]. One study used selected questions 
from the Delusion-Symptoms States Inventory with a cut-
off of 6, stating that this was in accordance with psychiatric 
opinion [33]. One used the Generalised Anxiety Disorder-7 
scale (GAD-7) with a validated cut-off of 10 or greater 
[34]. Another used the Spielberger State–Trait Anxiety 
Inventory (STAI-S) with a commonly agreed cut-point of 
40 or greater [35]. An abbreviated version of the Hopkins 
Symptom checklist was used by one study, with a positive 
response to 2 symptoms or strongly positive response to 1 
symptom indicating anxiety presence; a validated approach 
[36]. Another study used a single validated question about 
anxiety from the Perceived Health Questionnaire (PHQ): 
During the last two weeks, have you felt troubled by anxi-
ety? [37]. Another used a single question: Overall in the past 
30 days, how much of a problem did you have with worry 
or anxiety? [38]—with response alternatives: none, mild, 
moderate, severe, and extreme. Those who answered severe 
and extreme were classified as having anxiety; the approach 
taken by the World Health Survey. The remaining study used 
the Minnesota Multiphasic Personality Inventory (MMPI) in 
addition to psychiatric diagnosis, but did not explain how the 
MMPI scores were linked to diagnosis [18].
Community studies (Table 1)
Nine of the studies recruited participants from the commu-
nity settings. One reported lifetime prevalence, and the oth-
ers point prevalence.
nN = Number with anxiety / 
number in sample
ES (95% ES) = Effect Size 
(Prevalence) and 95% confidence 
intervals
HI=Hearing Impairment
* Indicates lower quality
Fig. 2  Forest plot of prevalence of anxiety disorder/symptoms in included studies
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Studies reporting diagnoses
Two community studies reported prevalence of anxiety 
disorder diagnoses. A very large study reported the preva-
lence of an archival ICD-9 diagnosis in a sample of 5043 
hearing-impaired people and 20,172 matched controls from 
a Taiwanese insurance database. It found an 11.1% lifetime 
prevalence of clinically diagnosed ‘unspecified anxiety dis-
order’ in the hearing impaired group compared to 5.4% in 
the controls (p value < 0.001) [24]. Specific anxiety disorder 
diagnoses were not considered by this study.
The other study reported that the prevalence of PTSD 
among 77 culturally Deaf people recruited from the Deaf 
community in the USA. The prevalence was 19.5% [8]. This 
study recruited a convenience sample, so was rated lower 
quality due to the potential for selection bias. Participants in 
this study had been deaf from childhood. All had a history 
of traumatic events.
Studies reporting symptoms
The other six community studies measured prevalence of 
anxiety symptoms. They collectively assessed 10,228 hear-
ing impaired people and 167,079 people in comparator 
groups. Four were of higher quality and took place in the 
USA, Sweden, Wales, and in Belgium using a global sample. 
They predominantly recruited people with acquired hearing 
loss and the reported prevalence of significant anxiety symp-
toms ranged from 15.4 to 31.3% [25, 33, 36, 38]. The study 
using the global (World Health Survey) sample included 
6,159 randomly selected people with self-reported hearing 
impairment and 165,869 controls across 42 countries mak-
ing it by far the largest study [38]. It assessed presence of 
anxiety using a single self-report question. It found a preva-
lence of 19.1% in the hearing impaired people compared 
to 8.7% in the non-hearing impaired sample, and following 
adjustment gave an odds ratio of anxiety presence in hearing 
impairment of 1.50 [95% CI 1.29–1.74].
Another study recruited people from the Swedish register 
for deaf adults and found a prevalence of significant anxiety 
symptoms of 41% in people with dual (visual and hearing) 
sensory loss, and 29% in people with only hearing impair-
ment [26].
Two studies were of lower quality due to relying on self-
selection of participants [31, 35]. One of these notably inves-
tigated people with early-onset deafness who were await-
ing testing for genetic causes of deafness in the USA and 
reported a 15.1% prevalence of significant anxiety symptoms 
[35]. The other looked at 98 older adults with hearing loss 
for speech and found a 32.7% prevalence of anxiety symp-
toms [31]. Every study that compared hearing impaired and 
non-hearing impaired people found a statistically significant 
higher prevalence of anxiety disorder or symptoms in the 
hearing impaired group [31, 33, 36, 38].
Summary
• In people with hearing impairment recruited from com-
munity samples, one large study reported an 11.1% life-
time prevalence of ‘unspecified anxiety disorder’.
• A global study with a very large sample reported a prev-
alence of self-reported anxiety over the past month of 
19.1% in the hearing impaired sample.
• Significant anxiety symptom prevalences of 15.4–31.3% 
were reported in five studies in people with predomi-
nantly acquired hearing impairment.
• One study reported a 41% prevalence of significant anxi-
ety symptoms in people with dual sensory loss.
• Every study that compared hearing impaired and non-
hearing impaired people found a higher prevalence of 
anxiety disorder or symptoms in the hearing impaired 
group.
Studies in ENT settings (Table 2)
We included 11 studies that recruited participants from ear 
nose and throat (ENT) hospital settings and reported point 
prevalence. Most of the 898 participants included in these 
studies had acquired hearing impairment and sample mean 
ages ranged from 45 to 70 years. The majority of these 
studies reported an objective method of identifying hear-
ing impairment including audiometry [17, 19, 27, 37] and 
speech recognition scores [16, 17, 27, 34], though the exact 
methods and thresholds used varied between studies.
Studies reporting diagnoses
Five studies assessed the prevalence of anxiety disorder 
diagnoses in a total of 252 hearing impaired people. Three 
of these were over 20 years old: one from UK ENT inpa-
tients reported a 4.6% prevalence of ‘anxiety state’ based 
on psychiatric interview in 1974 [19], and one reported an 
anxiety disorder prevalence of 2.2% in USA outpatients in 
1991 [17]. The other older study reported panic disorder 
prevalence in USA outpatients in 1994. It compared peo-
ple presenting with hearing impairment, of whom none had 
panic disorder, and people presenting with dizziness, of 
whom 20% had panic disorder [16].
Two studies were more recent; conducted in 2006 and 
2017. In one, outpatients awaiting cochlear implantation in 
Germany had a 39.9% prevalence of anxiety disorder [15]. 
The other study was of lower quality due to choosing a 
highly select group of patients, but reported an anxiety dis-
order rate of 60% in people presenting to an ENT outpatient 
clinic in Serbia for stapedectomy [18].
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Studies reporting symptoms
Six ENT studies collectively assessed 646 hearing-impaired 
people and measured the prevalence of anxiety symptoms. 
The participants were people presenting for cochlear implan-
tation in ENT outpatient clinics in Germany, The Nether-
lands, New Zealand, and Sweden [27, 28, 32], and in one 
case for audiological rehabilitation in Norway [37]. One 
study reported anxiety symptom prevalence in groups with 
hearing loss for speech or high-frequency sounds separately, 
with some overlap between groups [31]. To avoid count-
ing patients twice, only the loss for speech group’s results 
have been pooled across severity domains and reported in 
our review. The proportion scoring above the study-defined 
cut-points for anxiety symptoms across the studies of higher 
quality ranged from 13.5 to 38.6% [27, 28, 32, 37].
One study was deemed lower quality due to not clearly 
reporting the method of sample selection. It took place in 
an Egyptian ENT outpatient clinic and reported the preva-
lence of clinically significant anxiety symptoms to be 8.7% 
in people with hearing impairment without tinnitus and 86% 
in those with hearing impairment and tinnitus [30].
Pre‑ and post‑intervention ENT studies
Five of the above studies sampled patient groups before 
and at least 6 months after surgical intervention (cochlear 
implantation or stapedectomy) to improve acquired hear-
ing loss [15, 18, 28, 32, 34]. All but one [32] examined the 
same group longitudinally. Two were of lower quality due to 
unclear reporting of sample selection [18, 34]. Significantly 
fewer patients had anxiety symptoms in post-intervention 
groups compared to pre-intervention groups across all five 
studies (p values from < 0.001 to < 0.05). The absolute 
reduction in prevalence in post-intervention groups ranged 
from 1.9 to 30%.
Summary
• Across studies of higher quality, the reported anxiety 
prevalence in hearing impaired populations ranged from 
2.2 to 31.9% for any anxiety disorder, and 13.5–38.6% 
for presence of clinically significant anxiety symptoms.
• Anxiety symptoms were lower (by between 1.9 and 30%) 
after surgical intervention to improve hearing in all five 
studies assessing this.
Studies in mental health settings (Table 3)
Four studies assessed a period prevalence of diagnoses of 
any mental disorder in Deaf mental health services, which 
primarily treat pre-lingually and culturally Deaf adults 
[22]. All were of higher quality. The reported prevalence 
of anxiety disorder diagnoses ranged from 7.5 to 39.1%. 
Two studies from a USA inpatient unit and combined UK 
inpatient and outpatient services found the prevalence to 
be higher in deaf compared with hearing samples [9, 23]. 
One study reported an anxiety disorder prevalence of 18.7% 
in a USA outpatient unit and was the only study to report 
a prevalence of anxiety disorders that was higher in hear-
ing than deaf patients [20]. This may be because anxiety 
is commonly comorbid with other psychiatric disorders, so 
the comparator group also had elevated rates. The remaining 
study took place in a Netherlands’ outpatient unit and had 
no comparator group [22]. This found an anxiety disorder 
prevalence of 7.5%.
One study of higher quality recruited hearing impaired 
people from generic mental health services. It reported anxi-
ety disorder prevalence of 20% in 30 hearing impaired peo-
ple and 18% in 60 non-hearing impaired people [21].
Summary
• The reported prevalence of anxiety disorder in hear-
ing impaired mental health patients ranged from 7.5 to 
39.1%.
Correlates of anxiety symptoms
Tinnitus
Six studies explored the association between anxiety and 
tinnitus in hearing impaired populations. Five were in ENT 
settings and of these, two were of lower quality [30, 34]. The 
other was a community study [25]. Tinnitus severity was 
measured by various methods of self-report, including the 
Tinnitus Handicap Inventory, Tinnitus Questionnaire, and 
Tinnitus Handicap Questionnaire. Three of the studies found 
that people with hearing loss and tinnitus reported higher 
levels of anxiety than people with hearing loss only [15, 25, 
34]. One reported a reversal of post-intervention improve-
ments in depression and anxiety for patients who developed 
tinnitus [28]. Of the lower quality studies, one also found 
that longer tinnitus symptom duration, but not severity, was 
associated with higher rates of anxiety symptoms [30]. The 
other found that greater tinnitus handicap was significantly 
correlated with higher anxiety symptom score, following 
cochlear implantation but not prior to it [34].
Other factors linked to sensory impairment
Three studies assessed the relationship between hearing 
impairment severity and anxiety and all found a positive 
association [30, 31, 36]. Severity of hearing impairment 
was universally measured by audiometry. One study also 
noted an association between greater anxiety and longer 
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hearing impairment duration [30], but another did not find 
this [34]. The presence of visual impairment and vertigo 
also correlated with statistically higher anxiety levels [25, 
26]. Finally, the odds of reporting anxiety were found to 
increase significantly with increasing number of physical 
comorbidities [38].
Psychosocial factors
Higher disease-related quality-of-life score was associated 
with lower anxiety scores in two studies [15, 34]. In other 
studies, better communication and adaptation to loss [18]; 
active behaviour and the establishment of social interac-
tions; and active stress management all associated with 
lower anxiety following surgery [15].
Other factors
Although several of the studies looked for an association 
between anxiety and gender, statistical evidence of an 
association was not found [27, 30, 35, 36].
Summary
• Tinnitus was consistently associated with presence of 
anxiety in hearing impaired people in 6/6 studies exam-
ining this.
• Severity of hearing impairment was also identified as a 
correlate of anxiety in 3/3 studies examining this.
Discussion
Main findings
Anxiety prevalence was consistently higher in people with 
hearing impairment than comparison groups without hear-
ing impairment. Of the studies that reported anxiety preva-
lence in a comparator group, the prevalence was higher in 
the hearing impaired group in 8 studies [9, 21, 23, 24, 31, 
33, 36, 38]. This was not the case when a comparator group 
presenting with dizziness was assessed for panic disorder, 
which is perhaps unsurprising since dizziness is a symp-
tom of panic disorder [16]. There was just one exception to 
this where the comparator group had no reported physical 
comorbidity, though this group was selected from a psy-
chiatric population [20]. Anxiety is a common comorbidity 
with most other psychiatric conditions, which may explain 
this. Post-operative anxiety prevalences were lower than 
pre-operative prevalences in all five studies evaluating this 
in populations receiving surgical interventions to enhance S s
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hearing. People with hearing impairment were more likely 
to have clinically significant anxiety if they also experienced 
tinnitus [15, 25, 27, 28, 30, 34] and if their hearing impair-
ment was more severe [30, 31, 36].
Overall, our findings suggest that anxiety disorders and 
anxiety symptoms are likely to be higher in people with 
hearing impairment than the general population. The find-
ings that anxiety was related to hearing severity and that it 
decreased after surgical interventions to improve hearing are 
possible indications that the excess anxiety found in hear-
ing impaired population could result from the impairment 
itself rather than other influences, though this could not be 
assessed in this study.
Limitations
The studies included used different measures of anxiety, 
making it difficult to compare results across them. Some of 
the anxiety measures were not, to our knowledge, validated 
in a hearing impaired population. This might be particu-
larly important when considering participants whose first 
language is not a spoken language. Some studies measured 
anxiety through a small number of self-report questions [26, 
36], which may have been less reliable or valid than longer 
interview schedules. In the mental health service-based stud-
ies there was potential for cultural misunderstanding and 
language barriers to increase the risk of misdiagnosis among 
the deaf. For example, the grammar structure of British sign 
language could lead clinicians to wrongly conclude that a 
patient is thought-disordered based on their written com-
munication [39].
A number of studies did not describe the method of sam-
ple selection. Recent studies reported a higher prevalence of 
anxiety disorder based on standardised psychiatric interview 
than older studies, suggesting that diagnostic practices may 
have changed over time. This may also be because general 
population awareness of anxiety has increased. The stud-
ies included were heterogeneous in terms of how hearing 
impairment was measured; whether the hearing impairment 
was acquired pre- or post-lingually; recruitment source 
(clinical or non-clinical); and presence of additional condi-
tions such as tinnitus [25, 27, 28, 30], vertigo [25] or deaf-
blindness [26]. The variety of study settings may also be a 
strength of this review, as it captures a broad spectrum of 
Table 3  Studies from specialist mental health services
S selection, C comparability, O outcome, L low, M moderate, H high risk of bias, PTSD post-traumatic stress disorder
a From medical records
**Comparator Group Selected from same hospital or clinic
Author, year Adapted Newcastle–
Ottawa Scale Score
Setting and 
country
Sample Comparator 
sample
Anxiety disorder 
measure
Prevalence of 
anxiety disorder 
(95% confidence 
intervals)S C O Total/higher 
quality?
Appleford, 2003 
[23]
2 0 2 4
Yes
Inpatient and 
Outpatient Deaf 
Mental Health 
Service
UK
305 hearing 
impaired 
patients
621 hearing 
patients from 
same hospital or 
clinic
ICD-10 
 diagnosesa
17% (13.3–21.7)
8%**
De Bruin, 2004 
[22]
2 0 2 4
Yes
Outpatient Deaf 
Mental Health 
Service
The Netherlands
214 outpatients None DSM IV 
 diagnosesa
7.5% (4.7–11.8)
Black, 2006 [9] 2 0 2 4
Yes
Inpatient Deaf 
Mental Health 
Service
USA
64 hearing 
impaired 
patients
180 hearing 
patients from 
same hospital
DSM IV 
 diagnosesa
39.1% (28.1–51.3)
8.8%**
Landsberger, 2010 
[21]
2 0 2 4
Yes
Inpatient Mental 
Health Service
USA
30 deaf patients 60 hearing 
patients from 
same hospital
DSM IV-TR 
 diagnosesa
Diaz, 2013 [20] 2 1 2 5
Yes
Outpatient Deaf 
Mental Health 
Service
USA
241 deaf patients 345 hearing 
patients from 
same clinic
DSM IV 
 diagnosesa
18.7% (14.3–24.1)
30.1%**
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the hearing impaired population across countries and age 
ranges.
The studies based in mental health services reported rou-
tinely collected clinical data, so the procedures for making 
diagnoses may not have been standardised across services. 
This also introduced the possibility of diagnostic overshad-
owing, in which diagnosing a ‘major’ mental disorder such 
as psychosis might have been prioritised in a specialist 
service over assessment for common mental illness. The 
authors of the mental-health service-based study which 
found a lower anxiety prevalence in deaf people suggest 
that perhaps D/deaf people in their region had to be more 
severely unwell than hearing people to receive professional 
support, supporting diagnostic overshadowing as a potential 
explanation for the discrepant results compared to similar 
studies. Although it is tempting to infer from ENT studies 
that an improvement in hearing led to an improvement in 
anxiety, anxiety about the procedure itself may have led to 
the post-procedure reduction in anxiety. Consistent with this 
is the finding by one study that time on the waiting list was 
associated with stress [32].
We did not include non-English language studies and 
unpublished studies in the review. We excluded people under 
the age of 18, to ensure that findings were relevant to people 
referred to adult mental health services. Since our primary 
aim was to investigate prevalence, we only assessed corre-
lates of hearing impairment and anxiety in studies that also 
reported a prevalence. We have not considered depression, 
which is linked to anxiety. In fact it has recently been argued 
that generalised anxiety disorder is not a separate construct 
from depression [40]. Even with this debate, we would argue 
that it remains useful to look at common mental illness from 
the perspective of anxiety.
The Newcastle–Ottawa Scale (NOS) is not originally 
designed to be used with prevalence studies, and so we have 
had to adapt it to assess the quality of studies for this review 
and this approach is not validated.
A further limitation of our review is the scope of the 
question, which related only to prevalence and correlates. 
Hence no inference about the cause of heightened anxiety 
prevalence in hearing impaired people can be drawn from 
these results.
Implications
Based on these results, it appears that the prevalence of 
clinically significant anxiety in people with hearing impair-
ment is higher than for people without hearing impairment. 
Healthcare professionals should be alert to this, and have 
a low threshold for enquiring about anxiety when seeing 
people with hearing impairment, especially those with tin-
nitus or severe impairment. This should include making 
adaptations to communication where appropriate, such as 
through the use of hearing loops or sign language interpret-
ers. Anxiety is known to be a treatable with both psychologi-
cal therapies such as cognitive behavioural therapies (CBT) 
and medications [41]. The finding by one study that active 
behaviour and active stress management reduced anxiety fol-
lowing surgery suggests that CBT or behavioural therapy has 
potential to be effective [15]. The provision of mental health 
facilities competent in deaf culture for the pre-lingually Deaf 
population is also a key part of addressing the burden of 
anxiety disorders.
The mechanisms that might lead to increased prevalence 
of clinically significant anxiety in people with hearing 
impairment are not well-understood. Further research into 
the nature of the association is needed, ideally using longitu-
dinal cohorts. Social functioning, discrimination and abuse 
might mediate the relationship between hearing impairment 
and anxiety, and difficulty accessing mental health services 
might mean that people with hearing impairment live with 
anxiety disorders for longer.
In conclusion, the literature shows a considerable burden 
of anxiety symptoms and disorders in people with hearing 
impairment, and the prevalence appears to be higher than for 
people without hearing impairment. This review highlights 
the importance of making mental health services accessible 
for hearing impaired people and further investigating the 
nature of the association between hearing impairment and 
anxiety.
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